Celularity (CELU) Other Working Capital Changes (2020 - 2025)
Celularity's (CELU) quarterly Other Working Capital Changes came in at $49000.0 in Q4 2025, up 104.16% year-over-year from $24001.2 in Q4 2024, and down 62.88% quarter-over-quarter from $132000.0 in Q3 2025.
Analysis
Celularity (CELU) Other Working Capital Changes (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported Other Working Capital Changes for 6 consecutive years, with $49000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Other Working Capital Changes rose 104.16% year-over-year to $49000.0 in Q4 2025; TTM through Dec 2025 was $350000.0, a 138.67% increase from a year earlier, with the FY2025 full-year figure at $350000.0, up 138.67% from the prior year.
- Other Working Capital Changes was $49000.0 for Q4 2025 at Celularity, down from $132000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $6.0 million in Q4 2021 and troughed at -$5.6 million in Q3 2021.
- A 5-year average of -$387500.0 and a median of -$283000.0 in 2023 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes sank 2430.35% in 2021 and surged 80100.0% in 2023, its largest moves.
- Over 5 years, Other Working Capital Changes stood at -$9.9 million in 2021, then jumped by 104.65% to $461000.0 in 2022, then tumbled by 843.38% to -$3.4 million in 2023, then jumped by 65.6% to -$1.2 million in 2024, then surged by 104.16% to $49000.0 in 2025.
- The last three Other Working Capital Changes figures came in at $49000.0 (Q4 2025), $132000.0 (Q3 2025), and $420000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.24 Bn | 9.40 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.67 Bn | 3.37 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.55 Bn | 2.59 Bn | 251.50 Mn |
| 5 | uniQure | 2.96 Bn | 2.96 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Celularity | 36.35 Mn | 30.17 Mn | -3.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -294,000.00 |
| Dec 31, 2025 | -294,000.00 |
| Sep 30, 2025 | -914,000.00 |
| Sep 30, 2025 | -914,000.00 |
| Jun 30, 2025 | 92,000.00 |
| Jun 30, 2025 | 92,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | -612,000.00 |
| Dec 31, 2024 | -612,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Jun 30, 2024 | 467,000.00 |
| Jun 30, 2024 | 467,000.00 |
| Mar 31, 2024 | -181,000.00 |
| Mar 31, 2024 | -181,000.00 |
| Dec 31, 2023 | -2.15 Mn |
| Dec 31, 2023 | -2.15 Mn |
| Sep 30, 2023 | -1.14 Mn |
| Sep 30, 2023 | -1.14 Mn |